These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Continuous subcutaneous insulin infusion: improved blood-glucose and intermediary-metabolite control in diabetics. Pickup JC; Keen H; Parsons JA; Alberti KG; Rowe AS Lancet; 1979 Jun; 1(8129):1255-7. PubMed ID: 87724 [TBL] [Abstract][Full Text] [Related]
47. A new approach to improved metabolic control in diabetics: continuous subcutaneous insulin infusion. Pickup JC Am Heart J; 1980 Oct; 100(4):417-20. PubMed ID: 6998263 [No Abstract] [Full Text] [Related]
48. Insulin production rate in normal man as an estimate for calibration of continuous intravenous insulin infusion in insulin-dependent diabetic patients. Waldhäusl WK; Bratusch-Marrain PR; Francesconi M; Nowotny P; Kiss A Diabetes Care; 1982; 5(1):18-24. PubMed ID: 6754299 [TBL] [Abstract][Full Text] [Related]
49. Continuous subcutaneous insulin infusion:good blood glucose control for up to 4 days. Pickup JC; Keen H; Parsons JA; Alberti KG Diabetologia; 1979 Jun; 16(6):385-9. PubMed ID: 467848 [TBL] [Abstract][Full Text] [Related]
50. Treatment of diabetes mellitus by devices. Soeldner JS Am J Med; 1981 Jan; 70(1):183-94. PubMed ID: 7006391 [TBL] [Abstract][Full Text] [Related]
51. ABC of diabetes. Continuous subcutaneous insulin infusion. Pickup JC Br Med J (Clin Res Ed); 1982 Jul; 285(6334):49-50. PubMed ID: 6805809 [No Abstract] [Full Text] [Related]
52. Long-term continuous subcutaneous insulin infusion in diabetics at home. Pickup JC; White MC; Keen H; Parsons JA; Alberti KG Lancet; 1979 Oct; 2(8148):870-3. PubMed ID: 90966 [TBL] [Abstract][Full Text] [Related]
54. Clinical features of brittle diabetic patients unresponsive to optimized subcutaneous insulin therapy (continuous subcutaneous insulin infusion). Pickup J; Williams G; Johns P; Keen H Diabetes Care; 1983; 6(3):279-84. PubMed ID: 6409572 [No Abstract] [Full Text] [Related]
55. A portable system for continuous intravenous insulin delivery: characteristics and results in diabetic patients. Hanna AK; Minuk HL; Albisser AM; Marliss EB; Leibel BS; Zinman B Diabetes Care; 1980; 3(1):1-8. PubMed ID: 6996955 [No Abstract] [Full Text] [Related]
56. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Slama G; Hautecouverture M; Assan R; Tchobroutsky G Diabetes; 1974 Sep; 23(9):732-8. PubMed ID: 4414927 [No Abstract] [Full Text] [Related]
57. Restoration of normal lipid and aminoacid metabolism in diabetic patients treated with a portable insulin-infusion pump. Tamborlane WV; Sherwin RS; Genel M; Felig P Lancet; 1979 Jun; 1(8129):1258-61. PubMed ID: 87725 [TBL] [Abstract][Full Text] [Related]
58. Pump and brittle circumstance. Vaisrub S JAMA; 1980 Jun; 243(22):2331-2. PubMed ID: 6990038 [No Abstract] [Full Text] [Related]
59. [Peroperative insulin treatment]. Scherpereel P Ann Fr Anesth Reanim; 1985; 4(1):59-65. PubMed ID: 3885798 [No Abstract] [Full Text] [Related]